Flagship Biosciences Acquires Interpace Pharma Solutions expanding portfolio of analytics services
Flagship Biosciences, Inc., one of the leaders in spatial biology and biomarker analytics services, announced the acquisition of Interpace Pharma Solutions, a division of Interpace Biosciences and provider of cytogenetic, molecular pathology, and genomic profiling solutions. This acquisition follows a growth equity investment in Flagship from Ampersand Capital Partners, BroadOak Capital Partners, and Research Corporation […]
